Financials
- Fiscal year
- 2025
- Total assets
- €35,218
- Profit
- €24,700
- Solvency
- 78.7%
DE BOM CONSULT
ActiveSummary
DE BOM CONSULT has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €27,700 and a net result of €24,700. Its solvency ranks better than 70% of 2,941 sector peers (NACE 86, fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Overview
Activity
General medical practice
NACE 86210
1 site
Size
€35,218total assets 2025
- Equity
- €27,700
- Profit
- €24,700
Turnover not published (abridged schema)
Structure
Accounts 46 days early0 of 1 deed read
Why 98+ Sector Human health activities (NACE 86)+ Liquidity: current ratio 4.54, cash €30,711+ Figures for FY 2025 (filed 15-06-2026)+ Equity €27,700 (78.7% of total assets)Show the evidence
Checked score
Score 2025
98
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 80% of its sector peers (NACE 86, micro)
Financial strength
Strong
Solvency
100
equity 78.7% of total assets
Liquidity
93
short-term debt 21.3% · cash 87.2%
Profitability
100
return on assets 70.1%
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Credit up to €2,500 at 30 days acceptable
Liquidity ample (current ratio 4.54; short-term debt: 21.3% and cash: 87.2% of total assets), and 21.3% of the assets are financed with debt.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 79% on liquidity and 80% on profitability.
The bankruptcy probability was computed on 06-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals.
−lowers risk+raises risk○neutral
raises risk · Young company
Founded in 2025, under 3 years in business. Failure risk is statistically highest between 2 and 8 years after founding.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-06-2026, 46 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
46 days early
← before the deadline
after the deadline →
Checked, nothing found (1)
- Annual accounts filedfiscal year 2025 · abbreviated…
Key points
By topic
Timeline
- Events
- 1
- Since
- 2026
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- General medical practiceNACE 86210
- Founded
- 10-09-2025
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.